FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897863670> ?p ?o ?g. }

• W2897863670 endingPage "164" @default.
• W2897863670 startingPage "164" @default.
• W2897863670 abstract "Overexpression of human epidermal growth factor receptor type 3 (HER3) is associated with tumour cell resistance to HER-targeted therapies. Monoclonal antibodies (mAbs) targeting HER3 are currently being investigated for treatment of various types of cancers. Cumulative evidence suggests that affibody molecules may be appropriate alternatives to mAbs. We previously reported a fusion construct (3A3) containing two HER3-targeting affibody molecules flanking an engineered albumin-binding domain (ABD035) included for the extension of half-life in circulation. The 3A3 fusion protein (19.7 kDa) was shown to delay tumour growth in mice bearing HER3-expressing xenografts and was equipotent to the mAb seribantumab. Here, we have designed and explored a series of novel formats of anti-HER3 affibody molecules fused to the ABD in different orientations. All constructs inhibited heregulin-induced phosphorylation in HER3-expressing BxPC-3 and DU-145 cell lines. Biodistribution studies demonstrated extended the half-life of all ABD-fused constructs, although at different levels. The capacity of our ABD-fused proteins to accumulate in HER3-expressing tumours was demonstrated in nude mice bearing BxPC-3 xenografts. Formats where the ABD was located on the C-terminus of affibody binding domains (3A, 33A, and 3A3) provided the best tumour targeting properties in vivo. Further development of these promising candidates for treatment of HER3-overexpressing tumours is therefore justified." @default.
• W2897863670 created "2018-10-26" @default.
• W2897863670 creator A5002404985 @default.
• W2897863670 creator A5014071440 @default.
• W2897863670 creator A5016617825 @default.
• W2897863670 creator A5026833753 @default.
• W2897863670 creator A5040878207 @default.
• W2897863670 creator A5051852856 @default.
• W2897863670 creator A5058625511 @default.
• W2897863670 creator A5090698986 @default.
• W2897863670 creator A5091577187 @default.
• W2897863670 date "2018-10-11" @default.
• W2897863670 modified "2023-10-18" @default.
• W2897863670 title "Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs" @default.
• W2897863670 cites W1572912927 @default.
• W2897863670 cites W1578789128 @default.
• W2897863670 cites W1636690377 @default.
• W2897863670 cites W1965211843 @default.
• W2897863670 cites W1975275545 @default.
• W2897863670 cites W1983031498 @default.
• W2897863670 cites W1985312565 @default.
• W2897863670 cites W2000237324 @default.
• W2897863670 cites W2020248061 @default.
• W2897863670 cites W2025951140 @default.
• W2897863670 cites W2028415754 @default.
• W2897863670 cites W2035758624 @default.
• W2897863670 cites W2044037510 @default.
• W2897863670 cites W2059327554 @default.
• W2897863670 cites W2087865968 @default.
• W2897863670 cites W2094052190 @default.
• W2897863670 cites W2095724306 @default.
• W2897863670 cites W2108228534 @default.
• W2897863670 cites W2108796583 @default.
• W2897863670 cites W2112328645 @default.
• W2897863670 cites W2112512464 @default.
• W2897863670 cites W2117692326 @default.
• W2897863670 cites W2124076564 @default.
• W2897863670 cites W2127797287 @default.
• W2897863670 cites W2132840811 @default.
• W2897863670 cites W2144230749 @default.
• W2897863670 cites W2156214225 @default.
• W2897863670 cites W2159330187 @default.
• W2897863670 cites W2164622215 @default.
• W2897863670 cites W2285875128 @default.
• W2897863670 cites W2464855521 @default.
• W2897863670 cites W2469713970 @default.
• W2897863670 cites W2543492861 @default.
• W2897863670 cites W2561912709 @default.
• W2897863670 cites W2569188130 @default.
• W2897863670 cites W2589382713 @default.
• W2897863670 cites W2591723052 @default.
• W2897863670 cites W2593483585 @default.
• W2897863670 cites W2602095186 @default.
• W2897863670 cites W2613618878 @default.
• W2897863670 cites W2742314046 @default.
• W2897863670 cites W2865115571 @default.
• W2897863670 cites W4243575509 @default.
• W2897863670 doi "https://doi.org/10.3390/cells7100164" @default.
• W2897863670 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6210767" @default.
• W2897863670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30314301" @default.
• W2897863670 hasPublicationYear "2018" @default.
• W2897863670 type Work @default.
• W2897863670 sameAs 2897863670 @default.
• W2897863670 citedByCount "19" @default.
• W2897863670 countsByYear W28978636702019 @default.
• W2897863670 countsByYear W28978636702020 @default.
• W2897863670 countsByYear W28978636702021 @default.
• W2897863670 countsByYear W28978636702022 @default.
• W2897863670 countsByYear W28978636702023 @default.
• W2897863670 crossrefType "journal-article" @default.
• W2897863670 hasAuthorship W2897863670A5002404985 @default.
• W2897863670 hasAuthorship W2897863670A5014071440 @default.
• W2897863670 hasAuthorship W2897863670A5016617825 @default.
• W2897863670 hasAuthorship W2897863670A5026833753 @default.
• W2897863670 hasAuthorship W2897863670A5040878207 @default.
• W2897863670 hasAuthorship W2897863670A5051852856 @default.
• W2897863670 hasAuthorship W2897863670A5058625511 @default.
• W2897863670 hasAuthorship W2897863670A5090698986 @default.
• W2897863670 hasAuthorship W2897863670A5091577187 @default.
• W2897863670 hasBestOaLocation W28978636701 @default.
• W2897863670 hasConcept C104317684 @default.
• W2897863670 hasConcept C121608353 @default.
• W2897863670 hasConcept C123894998 @default.
• W2897863670 hasConcept C126322002 @default.
• W2897863670 hasConcept C150903083 @default.
• W2897863670 hasConcept C159654299 @default.
• W2897863670 hasConcept C170493617 @default.
• W2897863670 hasConcept C185592680 @default.
• W2897863670 hasConcept C202751555 @default.
• W2897863670 hasConcept C203014093 @default.
• W2897863670 hasConcept C207001950 @default.
• W2897863670 hasConcept C2777807558 @default.
• W2897863670 hasConcept C2779438470 @default.
• W2897863670 hasConcept C2781230642 @default.
• W2897863670 hasConcept C40767141 @default.
• W2897863670 hasConcept C502942594 @default.
• W2897863670 hasConcept C542903549 @default.
• W2897863670 hasConcept C55493867 @default.

• next